BNP Paribas Financial Markets’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $27 | Hold |
24
| – | – | ﹤0.01% | 4565 |
|
|
2025
Q1 | $30 | Hold |
24
| – | – | ﹤0.01% | 4473 |
|
|
2024
Q4 | $54 | Buy |
+24
| New | +$54 | ﹤0.01% | 4461 |
|
|
2024
Q3 | – | Sell |
-24
| Closed | -$123 | – | 3412 |
|
|
2024
Q2 | $123 | Hold |
24
| – | – | ﹤0.01% | 3278 |
|
|
2024
Q1 | $206 | Hold |
24
| – | – | ﹤0.01% | 3273 |
|
|
2023
Q4 | $99 | Hold |
24
| – | – | ﹤0.01% | 3236 |
|
|
2023
Q3 | $73 | Hold |
24
| – | – | ﹤0.01% | 3179 |
|
|
2023
Q2 | $750 | Hold |
24
| – | – | ﹤0.01% | 3157 |
|
|
2023
Q1 | $1.2K | Hold |
24
| – | – | ﹤0.01% | 3037 |
|
|
2022
Q4 | $597 | Hold |
24
| – | – | ﹤0.01% | 3184 |
|
|
2022
Q3 | $1.61K | Hold |
24
| – | – | ﹤0.01% | 3651 |
|
|
2022
Q2 | $1.01K | Sell |
24
-8
| -25% | -$335 | ﹤0.01% | 3267 |
|
|
2022
Q1 | $1.62K | Hold |
32
| – | – | ﹤0.01% | 3354 |
|
|
2021
Q4 | $1.92K | Hold |
32
| – | – | ﹤0.01% | 3345 |
|
|
2021
Q3 | $1.59K | Sell |
32
-95
| -75% | -$4.71K | ﹤0.01% | 3224 |
|
|
2021
Q2 | $7.23K | Sell |
127
-145
| -53% | -$8.25K | ﹤0.01% | 3179 |
|
|
2021
Q1 | $15.6K | Sell |
272
-136
| -33% | -$7.81K | ﹤0.01% | 3223 |
|
|
2020
Q4 | $27.7K | Sell |
408
-38
| -9% | -$2.58K | ﹤0.01% | 3121 |
|
|
2020
Q3 | $113K | Buy |
446
+379
| +566% | +$96.1K | ﹤0.01% | 2443 |
|
|
2020
Q2 | $11.2K | Buy |
+67
| New | +$11.2K | ﹤0.01% | 3028 |
|